Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

2965

Actual shortage: 229 (8%)
Anticipated shortage: 27 (1%)
Avoided shortage: 9 (0%)
Resolved: 2700 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

25 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYA 3.00MG 0.02MG TABLET Resolved 2017-03-11 2020-09-04 555
PIPERACILLIN AND TAZOBACTAM FOR INJECTION 3.0G 0.375G POWDER FOR SOLUTION Actual shortage 2017-03-11 2018-09-12 577
ZAMINE 21 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 558
ZAMINE 28 3.0MG 0.030MG TABLET Resolved 2017-03-11 2020-09-04 561
APO-RISPERIDONE 3.0MG TABLET Resolved 2020-06-10 2020-07-13 117407
APO-RISPERIDONE 3.0MG TABLET Resolved 2021-05-14 2021-06-21 139422
APO-CARVEDILOL 3.125MG TABLET Resolved 2020-06-10 2020-09-21 117348
APO-CARVEDILOL 3.125MG TABLET Anticipated shortage 2024-01-12 2024-01-26 215958
BORTEZOMIB 3.5MG POWDER FOR SOLUTION Resolved 2019-12-12 2019-12-21 101091
APO-GEMFIBROZIL CAP 300MG USP 300 MG CAPSULE Resolved 2017-03-11 2019-06-12 607
APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG TABLET Resolved 2017-12-06 2018-07-03 31907
APO-LAMIVUDINE-ZIDOVUDINE 300MG 150MG TABLET Resolved 2023-01-13 2023-01-20 181110
APO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 300MG 200MG 600MG TABLET Resolved 2023-04-14 2023-07-07 189653
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2017-09-27 2017-10-02 23663
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2018-03-05 2018-03-20 41868
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-04-04 2019-05-21 80530
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-07-12 2019-08-17 89158
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2019-09-04 2019-09-06 92974
APO-EMTRICITABINE-TENOFOVIR 300MG 200MG TABLET Resolved 2021-04-09 2021-06-07 137241
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 300MG 150MG TABLET Resolved 2017-03-10 2017-05-23 14

Showing 1681 to 1700 of 2965

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DICLO SR 75MG TABLET (EXTENDED-RELEASE) Discontinued 2017-03-31 2017-03-31 4915
APO-IRBESARTAN 75MG TABLET Discontinued 2019-01-04 2019-01-04 71231
APO-DIPYRIDAMOLE 75MG TABLET Discontinued 2019-12-20 2019-12-21 101880
APO-FUROSEMIDE 80MG TABLET Discontinued 2017-03-30 2018-02-05 4719
APO-SOTALOL 80MG TABLET Discontinued 2017-03-31 2018-12-07 4936
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40817
APO-TELMISARTAN 80MG TABLET Discontinued 2018-02-23 2018-09-15 40820
APO-ATORVASTATIN 80MG TABLET Discontinued 2018-09-07 2018-12-29 60285
APO-GLICLAZIDE 80MG TABLET Discontinued 2018-09-07 2018-09-15 60512
APO-ASA LD 81MG TABLET (DELAYED-RELEASE) Discontinued 2018-09-07 2018-09-15 60252
COATED DAILY LOW DOSE ASA 81 MG 81MG TABLET (DELAYED-RELEASE) Discontinued 2019-01-03 2019-01-04 71083
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60322
APO-CANDESARTAN 8MG TABLET Discontinued 2018-09-07 2018-09-15 60325
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977

Showing 341 to 356 of 356